Breaking News Instant updates and real-time market news.

SPLK

Splunk

$89.45

0.48 (0.54%)

05:05
01/12/18
01/12
05:05
01/12/18
05:05

Splunk price target raised to $100 from $85 at Deutsche Bank

Deutsche Bank analyst Karl Keirstead raised his price target for Splunk to $100 saying channel checks on the company's January quarter have been bullish. The analyst picked up evidence from several large customers and partners of a demand uptick, especially regarding the use of Splunk for security-related use cases. Checks reaffirm that the company's demand and execution are improving, Keirstead tells investors in a research note. He keeps a Buy rating on Splunk shares.

SPLK Splunk
$89.45

0.48 (0.54%)

11/20/17
BARD
11/20/17
NO CHANGE
Target $85
BARD
Outperform
Splunk price target raised to $85 from $75 at Baird
Baird analyst Rob Oliver raised his price target on Splunk to $85 from $75 following Q3 results. The analyst cited its raised guidance and the company's strength driven by new customers, increased average selling prices at existing customers, on premise business, and cloud transactions. Olive reiterated his Outperform rating on Splunk shares.
11/27/17
SBSH
11/27/17
NO CHANGE
Target $73
SBSH
Neutral
Splunk outlook well below consensus without ASC 606 impact, says Citi
Citi analyst Walter Pritchard believes Splunk's fiscal 2019 revenue guidance excluding the Accounting Standards Codification 606 impact is well below the consensus. Citing his estimates and management's commentary at analyst day, Pritchard sees the impact on revenue from the accounting change at $100M-plus and the corresponding impact on operating margin at 200 basis points, which he notes is the entire year-over-year margin expansion currently included in the guidance. Splunk shares rallied "substantially more than deserved" on the Q3 earnings report because of perceived strength in the guidance, Pritchard told investors earlier in a research note. The analyst believes more than all the "better" fiscal 2019 guidance is due to ASC 606. He keeps a Neutral rating on Splunk with a $73 price target. The stock in early trading is down 2c to $84.08.
12/18/17
BARD
12/18/17
NO CHANGE
Target $90
BARD
Outperform
Splunk price target raised to $90 from $85 at Baird
Baird analyst Rob Oliver raised his price target on Splunk to $90 from $85 citing a meaningful spike in job openings tracked by the firm, activity with the December year-end Federal security sending deadline, its competitive advantages, and modestly easier comps that are upcoming. Oliver reiterated his Outperform rating on Splunk shares.
01/08/18
LEHM
01/08/18
UPGRADE
Target $105
LEHM
Overweight
Splunk upgraded to Overweight from Equal Weight at Barclays
Barclays analyst Raimo Lenschow upgraded Splunk to Overweight and raised his price target for the shares to $105 from $80. The analyst sees the Security Event Management replacement cycle as a potential catalyst for positive estimate revisions.

TODAY'S FREE FLY STORIES

GERN

Geron

$1.49

-0.07 (-4.49%)

07:55
12/10/18
12/10
07:55
12/10/18
07:55
Conference/Events
Geron to hold an analyst and investor event »

Management, along with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 10

    Dec

  • 11

    Dec

PRMW

Primo Water

$13.57

-0.4 (-2.86%)

07:54
12/10/18
12/10
07:54
12/10/18
07:54
Recommendations
Primo Water analyst commentary  »

Primo Water weakness an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

DXPE

DXP Enterprises

$35.13

-0.42 (-1.18%)

07:54
12/10/18
12/10
07:54
12/10/18
07:54
Conference/Events
DXP Enterprises management to meet with Sidoti »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

MU

Micron

$35.31

-2.38 (-6.31%)

07:53
12/10/18
12/10
07:53
12/10/18
07:53
Recommendations
Micron analyst commentary  »

Micron price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

MRNS

Marinus Pharmaceuticals

$5.18

-0.12 (-2.26%)

07:52
12/10/18
12/10
07:52
12/10/18
07:52
Hot Stocks
Marinus Pharmaceuticals announces results from two ganaxolone studies »

Marinus Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DG

Dollar General

$102.71

-3.97 (-3.72%)

07:52
12/10/18
12/10
07:52
12/10/18
07:52
Conference/Events
Dollar General management to meet with Morgan Stanley »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 12

    Dec

TVTY

Tivity Health

$40.60

-0.27 (-0.66%)

, NTRI

Nutrisystem

$34.19

-1.07 (-3.03%)

07:50
12/10/18
12/10
07:50
12/10/18
07:50
Hot Stocks
Tivity Health sees double digit accretion from Nutrisystem deal in 2020, beyond »

In slides being presented…

TVTY

Tivity Health

$40.60

-0.27 (-0.66%)

NTRI

Nutrisystem

$34.19

-1.07 (-3.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

SWKS

Skyworks

$67.56

-3.04 (-4.31%)

, AAPL

Apple

$168.37

-6.37 (-3.65%)

07:50
12/10/18
12/10
07:50
12/10/18
07:50
Downgrade
Skyworks, Apple, Qualcomm, Qorvo rating change  »

Skyworks downgraded to…

SWKS

Skyworks

$67.56

-3.04 (-4.31%)

AAPL

Apple

$168.37

-6.37 (-3.65%)

QCOM

Qualcomm

$56.00

-1.1 (-1.93%)

QRVO

Qorvo

$61.16

-1.58 (-2.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

SIG

Signet Jewelers

$38.55

-2.515 (-6.13%)

07:48
12/10/18
12/10
07:48
12/10/18
07:48
Recommendations
Signet Jewelers analyst commentary  »

Signet Jewelers price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LULU

Lululemon

$113.83

-17.785 (-13.51%)

07:46
12/10/18
12/10
07:46
12/10/18
07:46
Recommendations
Lululemon analyst commentary  »

Lululemon pullback offer…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

07:46
12/10/18
12/10
07:46
12/10/18
07:46
General news
Stocks point to lower open as Huawei arrest tensions continue »

Stocks are pointing…

QRVO

Qorvo

$61.16

-1.58 (-2.52%)

, AAPL

Apple

$168.37

-6.37 (-3.65%)

07:46
12/10/18
12/10
07:46
12/10/18
07:46
Downgrade
Qorvo, Apple, Qualcomm rating change  »

Qorvo downgraded to…

QRVO

Qorvo

$61.16

-1.58 (-2.52%)

AAPL

Apple

$168.37

-6.37 (-3.65%)

QCOM

Qualcomm

$56.00

-1.1 (-1.93%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

MTN

Vail Resorts

$221.80

-50.15 (-18.44%)

07:45
12/10/18
12/10
07:45
12/10/18
07:45
Recommendations
Vail Resorts analyst commentary  »

Vail Resorts oversold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XNET

Xunlei

$4.88

-0.23 (-4.50%)

, CHL

China Mobile

$49.28

0.61 (1.25%)

07:44
12/10/18
12/10
07:44
12/10/18
07:44
Hot Stocks
Xunlei announces strategic partnership with China Mobile IoT »

Xunlei (XNET) announced…

XNET

Xunlei

$4.88

-0.23 (-4.50%)

CHL

China Mobile

$49.28

0.61 (1.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRZO

Carrizo Oil & Gas

$15.89

-0.47 (-2.87%)

07:43
12/10/18
12/10
07:43
12/10/18
07:43
Conference/Events
Carrizo Oil & Gas management to meet with Northland »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 12

    Dec

CONN

Conn's

$23.74

-1.25 (-5.00%)

07:42
12/10/18
12/10
07:42
12/10/18
07:42
Conference/Events
Conn's management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 13

    Dec

CONN

Conn's

$23.74

-1.25 (-5.00%)

07:42
12/10/18
12/10
07:42
12/10/18
07:42
Conference/Events
Conn's management to meet with KeyBanc »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 13

    Dec

QDEL

Quidel

$48.48

-12.835 (-20.93%)

07:41
12/10/18
12/10
07:41
12/10/18
07:41
Recommendations
Quidel analyst commentary  »

Quidel should be bought…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

SCWX

Secureworks

$15.65

-1.52 (-8.85%)

07:40
12/10/18
12/10
07:40
12/10/18
07:40
Downgrade
Secureworks rating change  »

Secureworks downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OSK

Oshkosh

$66.69

-1.38 (-2.03%)

07:40
12/10/18
12/10
07:40
12/10/18
07:40
Conference/Events
Oshkosh management to meet with SunTrust »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 11

    Dec

NOVN

Novan

$1.40

0.075 (5.68%)

07:40
12/10/18
12/10
07:40
12/10/18
07:40
Hot Stocks
Novan announces results from Phase 2 SB206 trial »

Novan announced full top…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RMD

ResMed

07:38
12/10/18
12/10
07:38
12/10/18
07:38
Upgrade
ResMed rating change  »

ResMed upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GILD

Gilead

$68.17

-2.01 (-2.86%)

07:38
12/10/18
12/10
07:38
12/10/18
07:38
Recommendations
Gilead analyst commentary  »

Gilead landing Daniel…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CGEN

Compugen

$3.30

-0.16 (-4.62%)

07:37
12/10/18
12/10
07:37
12/10/18
07:37
Conference/Events
Compugen management to meet with JMP Securities »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

MNLO

Menlo Therapeutics

$5.69

0.13 (2.34%)

07:37
12/10/18
12/10
07:37
12/10/18
07:37
Conference/Events
Menlo Therapeutics to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.